Characteristics of Vitiligo Patients in Dermatology and Venereology Outpatient Clinic Unit at Bali Mandara General Hospital 2021-2022

Main Article Content

Putu Sasmita Putri Mahadewi
Luh Putu Dina Wahyuni

Abstract

Vitiligo is a depigmentation disorder characterized by the distinct macules or depigmented patches, which are often asymptomatic. Age and geographic location have an impact on the prevalence of vitiligo. This condition affects 0.5-2% of the global population and is caused by a combination of factors, including clinical symptoms and therapeutic outcomes. Methods: The research material was taken from the medical record of vitiligo patients in the Outpatient Clinic Dermatovenerelogy Bali Mandara General Hospital from 2021-2022. The data were analyzed descriptively using SPSS program version 26 for Windows. Result: This study collected 198 visits from vitiligo patients at the Bali Mandara General Hospital Dermatovenereology outpatient clinic. The predominant gender is female (55.1%), with late adolescents comprising 36.4%, students accounting for 38.4%, and the development of vitiligo occurring within 1-5 years for 54% of cases; 63.1% of patients lacked a familial history of vitiligo. The predominant clinical kind is non-segmental vitiligo (59.1%), and the most frequently used treatment is excimer light phototherapy (85.9%). Conclusion: Vitiligo  patients  at  Bali Mandara hospital,     Denpasar,     mostly     female aged 17-25 years old,     with     non-segmental    vitiligo .    The    most    common    therapies    given  are  excimer light phototherapy.

Article Details

How to Cite
Mahadewi, P. S. P., & Luh Putu Dina Wahyuni. (2025). Characteristics of Vitiligo Patients in Dermatology and Venereology Outpatient Clinic Unit at Bali Mandara General Hospital 2021-2022. International Journal of Medical Science and Clinical Research Studies, 5(1), 1–4. https://doi.org/10.47191/ijmscrs/v5-i01-01
Section
Articles

References

I. Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571-592.

II. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clinical reviews in allergy & immunology. 2018;54:52-67.

III. Fitzpatrick Dermatology. 9th Ed. Vol. 1. United States: McGraw-Hill Education, 2019. Kedokteran.

IV. Siddiqua A, Rahaman MM, Siddique MRU, Asma AN, Akter S. Vitiligo Cases in the Out-Patient Department in a Tertiary Care Hospital. IAHS Medical Journal. 2024;7(1):17-21.

V. Saiboo AA, Prakoeswa CRS, Indramaya DM, Hidayati AN, Utomo B, Eliza F. Characteristics and Clinical Profile of Vitiligo Patients in Dermatology and Venereology Outpatient Clinic Unit at Dr. Soetomo General Academic Hospital Surabaya. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2023;35(1):1-5.

VI. Wongkar F, Winaya KK. Karakteristik pasien vitiligo di RSUP Prof. I GNG Ngoerah, Denpasar. Intisari Sains Medis. 2024;15(3):1025-1028.

VII. Yonathan EL. Vitiligo: Update of Pathogenesis and Treatment. Journal of Medicine and Health. 2023;5(1):95-109.

VIII. Rahmayanti ND. A Retrospective Study: The Profile of New Patient with Vitiligo. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2016;28(2):130-136.

IX. Dégboé B, Atadokpèdé F, Saka B, et al. Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin). International journal of dermatology. 2017;56(1):92-96.

X. Dwiyana RF, Marindani V, Agustina R, Setiawan, Idjradinata PS, Sutedja E. Profil Kliniko-Epidemiologi pada Pasien Vitiligo di RSUP Dr. Hasan Sadikin Bandung. MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL. 2017;49(2):132-138.

XI. Hariana M, Komarasari E, Esti PK. Profil Pasien Vitiligo di Rumah Sakit Dr. Sitanala Januari 2020–Juni 2023. Syntax Idea. 2024;6(3).

XII. Chakraborty AS, Agarwal R, Preethi P, Chandrashekar B. Clinico-Epidemiological Profile of Childhood Vitiligo. Indian Dermatology Online Journal. 2024;15(4):683-684.

XIII. Leung AK, Lam JM, Leong KF, Hon KL. Vitiligo: an updated narrative review. Current Pediatric Reviews. 2021;17(2):76-91.

XIV. Nurhadi S. Vitiligo Fokal pada Anak Yang Diterapi dengan Target Excimer Light 308 nm. 2019.